SHARP is an international, multi-site study that involves patients, family members, and clinicians in adapting LAMP and assessing its real-world use in predicting and preventing relapse. The observational study will be conducted by teams at 3 research sites - the Beth Israel Deaconess Medical Center in Boston, MA, the All India Institute of Medical Sciences (AIIMS) and Sangath in Bhopal, India, and the National Institute of Mental Health and Neuroscience (NIMHANS) in Bangalore, India. Spanning rural and urban settings and low to middle income patient populations, these institutions are a microcosm for the global population living with schizophrenia. At each site, 25 patients with early course schizophrenia will be offered use of LAMP to assess mood, cognition and symptoms over the course of a year.